Myocardial ischemia during intravenous DSA in patients with cardiac disease
Insights
Digital subtraction angiography (DSA) using hypertonic contrast media can trigger cardiac events in patients with angina. Special precautions are crucial for high-risk individuals undergoing these procedures.
Area of Science:
- Cardiology
- Radiology
- Medical Imaging
Background:
- Prospective study on 48 angina patients undergoing digital subtraction angiography (DSA).
- Cardiac disease severity assessed using American Heart Association (AHA) functional classification.
- Patients received multiple injections of hypertonic ionic contrast media (diatrizoate meglumine and diatrizoate sodium).
Observation:
- Patients in AHA functional Classes I/II showed 11% angina and 32% ischemic ECG changes post-DSA.
- Patients in AHA functional Class III experienced 63% angina and 58% ischemic ECG changes.
- One patient in Class IV developed ventricular fibrillation after contrast injection.
Findings:
- Hypertonic ionic contrast media administered via bolus injection can induce adverse cardiac events.
- Increased frequency and severity of cardiac events correlate with higher functional class of cardiac disease.
- Ischemic ECG changes and angina are significant post-procedural observations.
Implications:
- Intravenous DSA examinations require stringent precautions for high-risk cardiac patients.
- Risk-benefit assessment is critical before performing DSA on patients with severe angina.
- Further research into safer contrast agents or administration protocols for vulnerable populations is warranted.
Abstract:
A prospective study was performed for 48 patients who had histories of angina and were referred for digital subtraction angiography (DSA). Cardiac disease was graded according to the American Heart Association (AHA) functional classification system. Each patient received 2-5 injections of 40-ml diatrizoate meglumine and diatrizoate sodium (Renografin-76, Angiovist-370, or MD-76) at 15 ml per second in the superior vena cava. Of the 28 patients in functional Classes I or II (no or slight limitation of activity), 11% had angina and 32% had definite ischemic ECG changes after the DSA injections. Of the 19 patients in functional Class III (marked limitation of activity), 63% had angina, and 58% had definite ischemic ECG changes after the injections. One patient in functional Class IV (total disability) developed ventricular fibrillation after the second injection. These observed cardiac effects following bolus injections of hypertonic ionic contrast media indicate that special precautions are necessary when performing intravenous DSA examinations on this group of high risk patients.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Cardiac Catheterization IV: Nursing Management
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy


